Retatrutide is not yet FDA-approved. Here is a complete, honest guide to every current access pathway — research peptide vendors, compounding pharmacies, and clinical trials — with current pricing and what to watch out for.
As of early 2026, there are three distinct pathways through which retatrutide is accessible. Each comes with meaningfully different costs, risks, oversight levels, and legal considerations.
Research peptide vendors are the most widely used access route in 2026. These companies synthesize and sell retatrutide as a lyophilized (freeze-dried) powder labeled strictly for laboratory research. The quality varies enormously between vendors — third-party Certificates of Analysis (COA) using HPLC and mass spectrometry are the minimum standard to look for.
Below are the vendors we have independently verified carry retatrutide with confirmed third-party testing:
Colorado-based. Every product page links to its third-party COA. Stocks retatrutide, tirzepatide, and a full GLP-1 catalog. Phone support available.
Shop Ascension Peptides →The highest independently verified testing depth of any US vendor. Finnrick Analytics — a third-party lab service — rated them #1 across 59 tests and 7 products. Carries retatrutide with full COA documentation.
Shop Peptide Partners →One of the most established US vendors. 4.8+ stars across hundreds of verified reviews. Competitive pricing, fast shipping, excellent customer service.
Shop Biotech Peptides →Florida-based. Highly regarded in the r/Peptides community for detailed impurity profiling. GLP-1 compounds are gated behind a free VIP membership.
Visit Limitless Life →Newer vendor with strong testing standards. Accepts all major cards, PayPal, Apple Pay, Venmo, and crypto. Best for bulk purchases.
Visit Apollo Peptide Sciences →For a full side-by-side breakdown of all vendors including BPC-157 pricing, shipping thresholds, and testing details, see our complete vendor comparison page.
The research peptide market is largely unregulated. Quality ranges from pharmaceutical-grade synthesis to outright counterfeit. Before purchasing from any vendor, verify each of the following:
| Source Type | Approx. Cost | Prescription | FDA Oversight | Physician Supervised |
|---|---|---|---|---|
| Research Peptides | $9–$20/mg (~$150–500/mo) | ✗ No | ✗ No | ✗ No |
| Compounding Pharmacy | $200–600/month | ✓ Yes | Partial | ✓ Yes |
| Clinical Trial | Free | N/A | ✓ Full | ✓ Yes |
| Commercial (projected) | ~$1,000–1,500/mo (est. 2027–28) | ✓ Yes | ✓ Full | ✓ Yes |
If you meet eligibility criteria, enrolling in a TRIUMPH program clinical trial is the only route that provides fully supervised, FDA-regulated access to retatrutide at no cost. Eli Lilly is currently running multiple Phase 3 trials across obesity, type 2 diabetes, sleep apnea, liver disease, and osteoarthritis.
Typical eligibility for the obesity trials requires a BMI ≥30 (or ≥27 with a weight-related comorbidity) and no current use of other GLP-1 medications. Search for open sites at clinicaltrials.gov — search "retatrutide" or "LY3437943."
When will retatrutide be commercially available? Based on the TRIUMPH Phase 3 timeline and Eli Lilly's regulatory history with tirzepatide, analysts project an NDA submission in late 2026 or 2027, with potential FDA approval and commercial launch in 2027–2028. At that point, pricing is expected to follow Zepbound's trajectory — approximately $1,000–$1,500/month before insurance.
Research peptide retatrutide is shipped as a lyophilized (freeze-dried) powder and must be reconstituted with bacteriostatic water before use. Proper handling is critical to maintaining peptide integrity:
Continue your research with these related guides on retatrutide-rx.com: